NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Short-Term Capital Lease Obligation : $0.06 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Short-Term Capital Lease Obligation?

NewAmsterdam Pharma Co NV's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.06 Mil.

NewAmsterdam Pharma Co NV's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.07 Mil) to Jun. 2023 ($0.07 Mil) but then declined from Jun. 2023 ($0.07 Mil) to Dec. 2023 ($0.06 Mil).

NewAmsterdam Pharma Co NV's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($0.06 Mil) to Dec. 2022 ($0.07 Mil) but then declined from Dec. 2022 ($0.07 Mil) to Dec. 2023 ($0.06 Mil).

NewAmsterdam Pharma Co NV Short-Term Capital Lease Obligation Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Short-Term Capital Lease Obligation Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.06

0.07

0.06

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			0.06	0.06	0.07	0.07	0.06

NewAmsterdam Pharma Co NV Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

NewAmsterdam Pharma Co NV Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (NewAmsterdam Pharma Co NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (NAS:NAMS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.